Power Law company profile

Biocytogen

Biotech & Life Sciences · Wakefield, United States · Founded 2009 · IPO 2022 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$5.15B

Market cap · Apr/2026

Revenue

$190M

Latest reported FY

Investors

7 investors on Biocytogen's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 7 investors entered at this stage

Cowin Capital

CMB International Capital

SDIC Venture Capital

CMB International

China Resources Pharmaceutical Group Limited

3E Bioventures

Oriza Holdings

Global footprint

Where Biocytogen has talent and traffic

Web traffic by country

23K monthly visits
across markets

🇺🇸 United States33.5%

🏳️ Korea24.3%

🏳️ Republic of6.5%

🇬🇧 United Kingdom6.1%

🇨🇦 Canada6.1%

Top 5 markets shown

Patent intelligence

$63M patent portfolio · 276 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$63M

1.2% of market cap · 32.4× smaller than top peer Ablynx ($2B)

276 active patent families

Where Biocytogen innovates Molecular biologyBiotechnologyGenetically modifyAnimal modelCell biology

Below peer median on Strategic, Market

Quality vs same-sector peers

Biocytogen on the five Patsnap quality dimensions

Biocytogen in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Biocytogen concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Biocytogen and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Biocytogen on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo